PKPernille Koefoed

Pernille Koefoed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pernille Koefoed has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neuropeptide Y genes and suicidal behaviour among schizophrenic patients

    by August G. Wang, Pernille Koefoed, Anne S. Jacoby, David Woldbye, Henrik B. Rasmussen, Sally Timm, Henrik Dam, Klaus D. Jakobsen, Merete Nordentoft, Gesche Jürgens, et al.


  • Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression

    by Pernille Koefoed, David P.D. Woldbye, Thomas V. O. Hansen, Lene F. Eplov, Søren H. Christiansen, Ole Mors, Lars V. Kessing, Thomas Werge, Katja Kaipio, Ullamari Pesonen, et al.

    Objective:There is clear evidence of a genetic component in major depression, and several studies indicate that neuropeptide Y (NPY) could play an important role in the pathophysiology of the disease. A well-known polymorphism encoding the substitution of leucine to proline in the signal peptide sequence of NPY (Leu7Pro variation) was previously found to protect against depression. Our study aimed at replicating this association in a large Danish population with major depression. Method:Leu7Pro was studied in a sample of depressed patients and ethnically matched controls, as well as psychiatric disease controls with schizophrenia. Possible functional consequences of Leu7Pro were exploredin vitro. Results:In contrast to previous studies, Pro7 appeared to be a risk allele for depression, being significantly more frequent in the depression sample (5.5%,n= 593;p= 0.009; odds ratio, OR: 1.46) as compared to ethnically matched controls (3.8%,n= 2912), while schizophrenia patients (4.1%,n= 503) did not differ.In vitro, the Pro7 substitution appeared to be associated with reduced levels of NPY without affecting its mRNA level. Conclusion:The Leu7Pro variation may increase the risk of major depression, possibly by affecting the biosynthesis of NPY.


  • Open Access

    Combinations of SNPs Related to Signal Transduction in Bipolar Disorder

    by Pernille Koefoed, Ole A. Andreassen, Bente Bennike, Henrik Dam, Srdjan Djurovic, Thomas Hansen, Martin Balslev Jorgensen, Lars Vedel Kessing, Ingrid Melle, Gert Lykke Møller, et al.

    Any given single nucleotide polymorphism (SNP) in a genome may have little or no functional impact. A biologically significant effect may possibly emerge only when a number of key SNP-related genotypes occur together in a single organism. Thus, in analysis of many SNPs in association studies of complex diseases, it may be useful to look at combinations of genotypes. Genes related to signal transmission, e.g., ion channel genes, may be of interest in this respect in the context of bipolar disorder. In the present study, we analysed 803 SNPs in 55 genes related to aspects of signal transmission and calculated all combinations of three genotypes from the 3×803 SNP genotypes for 1355 controls and 607 patients with bipolar disorder. Four clusters of patient-specific combinations were identified. Permutation tests indicated that some of these combinations might be related to bipolar disorder. The WTCCC bipolar dataset were use for replication, 469 of the 803 SNP were present in the WTCCC dataset either directly (n = 132) or by imputation (n = 337) covering 51 of our selected genes. We found three clusters of patient-specific 3×SNP combinations in the WTCCC dataset. Different SNPs were involved in the clusters in the two datasets. The present analyses of the combinations of SNP genotypes support a role for both genetic heterogeneity and interactions in the genetic architecture of bipolar disorder.


  • Gene variations in the cholecystokinin system in patients with panic disorder

    by Pernille Koefoed, David P. Woldbye, Thomas O. Hansen, Elsebeth S. Hansen, Gitte M. Knudsen, Tom G. Bolwig, Jens F. Rehfeld

    Objectives Panic disorder (PD) is a common psychiatric disease occurring more frequently in women than men. Multiple common and/or rare variants in the genome contribute to the complex etiology of the disorder. The neuropeptide cholecystokinin (CCK) and its receptors (the CCK system) have been suggested to be involved in the pathogenesis of PD. Methods We examined the promoter, exon, and exon–intron boundaries of the genes encoding CCK and its receptors (CCKAR and CCKBR) for variations in 187 patients with PD and 277 screened control individuals. Up to 1342 additional healthy population controls were examined for some of the variations. One CCK gene intron variation was analyzed for alternative splicing using an exon-trapping assay. Results The promoter variant (−36C > T; rs1799923) and an intron 1 polymorphism (IVS1-7C > G; rs754635) in the CCK gene were found to protect against PD (PP=0.004). In addition, we found two novel rare missense variations in the CCKBR gene (Lys329Asn and Pro446Leu) in two and one patient, respectively. Conclusion The results suggest that the CCK system may play a role in the pathogenesis of PD, with susceptibility alleles both protecting and contributing to the disease. Both common and rare variants seem to be involved. The involvement of the CCK system may also contribute to the increased prevalence of PD in women.


  • An intron 1 polymorphism in the cholecystokinin-A receptor gene associated with schizophrenia in males

    by P. Koefoed, T. V. O. Hansen, D. P. D. Woldbye, T. Werge, O. Mors, K. D. Jakobsen, M. Nordentoft, A. Wang, T. G. Bolwig, J. F. Rehfeld

    To identify whether a genetic variation (rs1800857; IVS1-5T>C) in the neuropeptide cholecystokinin-A receptor (CCKAR) gene is a risk factor in the pathogenesis of schizophrenia. The variation was analysed in a case-control design comprising 508 patients with schizophrenia and 1619 control subjects. A possible functional impact of this variant on CCKAR protein synthesis through alterations in splicing was analysed in an exon-trapping assay. In males only, the risk variant, IVS1-5C, was associated with a significantly increased risk of schizophrenia. Carrying one risk allele was associated with an increased risk of 1.74 (Odds Ratio, OR) and homozygosity (CC) was associated with an OR of 3.19. The variation had no impact on protein synthesis of CCKAR. This is the first report associating the CCKAR gene variant with schizophrenia specifically in men. Our study strengthens the conclusion that a CCKAR dysfunction could be involved in the aetiology of schizophrenia.